Biomarker Discovery & Validation

Quest Diagnostics teams up with Envision Science on prostate cancer biomarkers

The test aims to improve the accuracy of grading biopsies for prostate cancer, which is one of the most prevalent and deadly cancers affecting men.

July 27, 2023

Physicians advocate for ‘careful’ use of osteoporosis bone turnover marker testing

Knowing the rate of bone matrix removal or deposition can help physicians understand if a patient is at risk of fractures or is responding to treatment.

July 24, 2023

Quest launches biomarker test to improve grading of prostate cancer biopsies

Building on the Australian research and working with Envision Sciences, the Australian diagnostics company that owns the biomarker intellectual property, Quest’s subspecialty pathology business, AmeriPath, has developed a tissue-based test.

July 17, 2023

DiamiR Biosciences partners with JADBio on diagnostic tests, validation for biomarker panels

Under the deal, DiamiR will apply the capabilities of JADBio’s Automated Machine Learning (AutoML) bioinformatics platform and services to its own microRNA platform.

July 12, 2023

Intus Bio buys Pattern Genomics to enhance microbiome analysis capabilities

Intus Bio sees the integration enhancing the platform with machine-learning tools for biomarker discovery and patient stratification, supporting the firm’s work in turning microbiome technologies into practical medical and pharmaceutical applications.

June 29, 2023

Nucleai, Mayo Clinic partner on digital pathology

The collaboration combines Nucleai’s AI-enabled spatial biology technology with Mayo’s longitudinally annotated, multimodal data sets, lab services, and clinical diagnostic footprint.

June 5, 2023

Blood biomarker in study predicts whether the cognitively healthy will develop Alzheimer’s

Astrocytes -- a subtype of glial cells that make up most cells in the human central nervous system -- may be the key driver of Alzheimer's disease progression, researchers said.

May 30, 2023

Biomarkers may predict stem cell transplant risks

A biomarker for donor stem cell transplant risk may help doctors predict which patients will develop potentially deadly sinusoidal obstruction syndrome.

May 23, 2023

Biomarker predicts response to chemo-immunotherapy in lung cancer patients

Researchers see a correlation between CX3CR1 expression and outcomes in NSCLC patients treated with chemo-immunotherapy.

May 15, 2023

Hallmark Parkinson’s disease protein may aid early detection

Identifying hallmark Parkinson’s disease misfolded protein deposits could aid early detection and pave the way for improved diagnosis and treatment.

April 12, 2023

Simple blood test can detect PTSD biomarkers

People at risk or suffering from post-traumatic stress disorder show specific patterns in four biomarkers measurable with a simple blood test.

March 28, 2023

AriBio, Fujirebio partner on biomarker development for Alzheimer’s, other neurodegenerative disorders

The agreement will provide Fujirebio access to clinical samples and data that have been collected in an ongoing phase III Alzheimer’s disease study being conducted by AriBio.

March 8, 2023

Page 1 of 4

Next Page